Skip to main content
IDWeek 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

Z9. COVID-19 Special populations (e.g. pregnant women, children, immunocompromised, etc)

Poster Session: COVID-19: Special Populations

(P-1989) COVID-19 Mortality Among Immunocompromised Individuals is Consistently High Compared with Non-Immunocompromised Individuals: Results of the INFORM Study 2022, England

Saturday, October 19, 2024
12:15 PM – 1:30 PM US PT
Location: Halls JK

    Co-Author(s)

  • LC

    Lucy Carty, PhD

    AstraZeneca
    Cambridge, England, United Kingdom

  • SD

    Sabada Dube, PhD (he/him/his)

    Director of Epidemiology
    Medical Evidence, Vaccines and Immune Therapies Unit, AstraZeneca
    Cambridge, England, United Kingdom

    • Presenting Author(s)

  • CT

    Carla Talarico, PhD, MPH (she/her/hers)

    Director
    Vaccines and Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA
    Gaithersburg, Maryland, United States

    • Co-Author(s)

  • RM

    Richard McNulty, MD

    Medical Affairs, Vaccines and Immune Therapies Unit, AstraZeneca, Cambridge, UK
    Cambridge, England, United Kingdom

  • NJ

    Nahila Justo, PhD, MBA

    Real-World Evidence, Data Analytics, Evidera, Stockholm, Sweden and Department of Neurobiology, Care Science and Society, Karolinska Institute, Stockholm, Sweden
    Stockholm, Sodermanlands Lan, Sweden

  • RY

    Renata Yokota, PhD

    P95, Leuven, Belgium
    Dilbeek, Luxembourg, Belgium

  • MH

    Michelle Harley, MBBS, MRCP, MRCGP

    AstraZeneca
    London, England, United Kingdom

  • JP

    Jurgens Peters, MD, MPH, MSc, MBA

    AstraZeneca
    London, England, United Kingdom

  • KE

    Kathryn Evans, MPH

    Real-World Evidence, Data Analytics, Evidera, Waltham, MA, USA
    Waltham, Massachusetts, United States

  • YL

    Yi Lu, PhD

    Real-World Evidence, Data Analytics, Evidera, London, UK
    London, England, United Kingdom

  • ST

    Sylvia Taylor, PhD, MPH, MBA

    Medical Evidence, Vaccines and Immune Therapies Unit, AstraZeneca, Cambridge, UK
    Cambridge, England, United Kingdom

  • JQ

    Jennifer Quint, PhD

    National Heart and Lung Institute, Imperial College London, London, UK
    Cambridge, England, United Kingdom

  • RE

    Rachael A. Evans, PhD FRCP

    Associate Professor and Honorary Respiratory Consultant Physician
    University of Leicester
    Leicester, England, United Kingdom